We’re here for you every step of the testing process
Whether you’re just learning about the FoundationOne®CDx test or are further along in the testing process, we’re dedicated to providing the resources, support, and assistance you and your loved ones need.
Coverage information and financial resources
FoundationAccessTM program
Foundation Medicine is committed to providing patients with resources and support throughout the testing process with the help of the FoundationAccessTM program.
All Foundation Medicine tests are covered by Original Medicare and Medicare Advantage for qualifying patients. Qualifying patients with Original Medicare have no out-of-pocket costs for Foundation Medicine comprehensive genomic profiling (CGP) tests.1
Health plans such as Cigna and many Blue Cross Blue Shield plans offer coverage for Foundation Medicine testing services.2 We will work directly with your insurance company to try to obtain coverage.
Financial assistance is available for qualifying patients who have out-of-pocket costs associated with Foundation Medicine testing.* Financial assistance is based on need and can be applied for at any time before, during, or after testing by filling out a financial assistance application at
.*Foundation Medicine’s FoundationAccessTM program is only available to patients whose tests were ordered within the United States and U.S. territories.
How to apply
Fill out a Financial Assistance Application or
Download a PDF Application to apply for assistance.
For more information
Call our Care Team at +1 (888) 988-3639 8AM-8PM EST or
We will be in touch
After your doctor orders a test and our lab receives your sample, we’ll reach out to you by phone, or mail, with important information about what you can expect as your test moves forward.
Important resources for help and support
Knowledge is power. We’ve created the following resources to help you and your loved ones feel educated and confident as you make decisions around your cancer care.
Patient Guide to CGP
For a deeper understanding of Comprehensive Genomic Profiling, the Foundation Medicine testing process, and financial support, this brochure helps explain.
The Foundation Medicine Tests FAQ
Have a question in mind? Find answers to common questions about testing.
Advanced Cancer Glossary
Get familiar with certain words you may hear or read when learning about advanced cancer and Foundation Medicine testing.
You are your best advocate.
Ask your doctor about the FoundationOne CDx test. This guide will help prepare you for the discussion.
Video library
Cancer Explained
Watch this video for a simple explanation of the basics of cancer and common treatment options.
The Science Behind Cancer and CGP
See how CGP may help you understand which treatment options may work best.
Ed and Sandy’s Story
See how the FoundationOne CDx test helped a patient with Stage 4 colon cancer and his loved one create a personalized cancer treatment plan together.
*Metastatic colorectal cancer (mCRC) is a complex disease, and mCRC patients have a 14% survival rate five years after their diagnosis.3 43% of mCRC patients are matched to an on-label therapy, but a match does not guarantee that the treatment is right for a patient or that a patient will achieve a similar outcome.4 Speak with your doctor for more information.
*Metastatic colorectal cancer (mCRC) is a complex disease, and mCRC patients have a 14% survival rate five years after their diagnosis.3 43% of mCRC patients are matched to an on-label therapy, but a match does not guarantee that the treatment is right for a patient or that a patient will achieve a similar outcome.4 Speak with your doctor for more information.
Join our community
Thank you!
You’re all set. We will be in touch soon!
Stay connected. Stay informed.
Advanced cancer can come with many unknowns. Foundation Medicine is committed to keeping you and your loved ones informed, educated, and empowered. Sign up to receive email updates from us.
By clicking Sign Up, you agree to our privacy policy and terms of use.
Medicare and Medicare Advantage members have coverage of FoundationOne CDx, FoundationOne Liquid CDx, and FoundationOne®Heme in accordance with the Centers for Medicare and Medicaid Services (CMS) national coverage determination (NCD) criteria.
A select number of commercial payers have developed medical policy coverage for Foundation Medicine’s FoundationOne CDx and FoundationOne Liquid CDx tests for commercially insured patients. Foundation Medicine’s other CGP test (FoundationOne Heme) has limited third-party payer commercial coverage. In each case, coverage is pursuant to applicable payer medical policy and patient benefit plans.
American Cancer Society. Cancer Facts & Figures 2021. Atlanta, GA: American Cancer Society; 2021.
Data on file. Foundation Medicine, 2020.
